Abstract
The management of myelodysplastic syndrome (MDS) and chronic myelomonocytic leukemia (CMML) is limited and remains an unmet need. Decitabine/cedazurid......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
